This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

33/100

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Diet and specific nutritional factors, alone and in combination with other lifestyle approaches, have an important role in decreasing the risk for dementia. Protective factors for dementia risk reduction are important in early as well as late adult life, since pathological processes underlying dementia begin years before clinical symptoms appear. Decreased levels of nutrients, such as B vitamins and omega-3 fatty acids, exacerbate pathological processes contributing to cognitive impairment. Initial work using specific diets, including the MIND diet (which combines elements of the Mediterranean and DASH diets), has shown potential to reduce the risk of cognitive decline and/or improve cognitive function, but further research is required. Although the benefits of single-agent nutrient supplementation are unclear, the LipiDiDiet trial has indicated that multinutrient supplementation with Fortasyn Connect may have the potential to improve cognitive function and decrease disease progression in individuals with prodromal Alzheimer's disease. The worldwide FINGER studies are assessing the potential benefits of multidomain lifestyle-based interventions in the prevention of cognitive decline, including dietary interventions. Evidence for the importance of nutrition in combination with lifestyle approaches in maintaining a healthy brain indicates that public health policy must consider nutrition and diet when targeting dementia risk reduction and healthy aging.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rasmussen, J. (2026). Perspectives in dementia risk reduction – food for thought. Neurodegenerative Disease Management. https://doi.org/10.1080/17582024.2026.2669599

Vancouver

Rasmussen J. Perspectives in dementia risk reduction – food for thought. Neurodegenerative Disease Management. 2026. doi:10.1080/17582024.2026.2669599. PMID: 42112907.

BibTeX

@article{rasmussen2026-42112907,
  author  = {Rasmussen, Jill},
  title   = {{Perspectives in dementia risk reduction – food for thought}},
  journal = {Neurodegenerative Disease Management},
  year    = {2026},
  doi     = {10.1080/17582024.2026.2669599},
  pmid    = {42112907},
  url     = {https://doi.org/10.1080/17582024.2026.2669599}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Although the benefits of single-agent nutrient supplementation are unclear, the LipiDiDiet trial has indicated that multinutrient supplementation with Fortasyn Connect may have the potential to improve cognitive function and decrease disease progression in individuals with prodromal Alzheimer's disease.
Evidence for the importance of nutrition in combination with lifestyle approaches in maintaining a healthy brain indicates that public health policy must consider nutrition and diet when targeting dementia risk reduction and healthy aging.

Why it matters

This review says diet and nutrition may help lower dementia risk, but it notes that more research is needed and that the benefits of single-nutrient supplements are unclear. It reports that the LipiDiDiet trial suggested a multinutrient supplement may improve cognitive function and slow progression in people with prodromal Alzheimer's disease.

New to this subject? Start with our plain-English guide: Prevention →

Study details

Evidence strengthLow

How this study scored 33/100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 32 of the 97 points we could judge it on, which is 33 out of 100.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Neurodegenerative Disease Management)
Journal's citation record	0 / 4	Neurodegenerative Disease Management: journal h-index 47 (OpenAlex, 2026-10-29)
Study design	0 / 12	No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence	1 / 5	Rated “low” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	5 / 5	2026 — within 1 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	0 / 3	No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	0 / 2	No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited	1 / 7	Cited 1 times (OpenAlex, 2026-10-10)
Citations per year	0 / 5	0.5 citations a year over 2 year(s) since 2026
Impact for its field and year	3 / 6	Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	0 / 6	No other study in this library cites it
Still being cited	0 / 4	Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	1 / 4	Last-listed author Jill Rasmussen: h-index 10 (OpenAlex, whole career)
Institution's track record	— / 3	No institution listed in OpenAlex — left out of this score
Multi-centre collaboration	0 / 3	OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 42112907)
Free to read	2 / 2	Free to read
Points	32 / 97	Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 32 of the 97 points we could judge it on is 33 out of 100.
Total	33 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 22.

Related studies in Prevention and risk

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →